Taking DCB technology to a New High
Drug-coated balloon (DCB) treatment is based on a leave-nothing-behind concept. DCB offers homogeneous
drug delivery to the vessel wall, immediate drug release without the use of a polymer, the potential of reducing
the intensity and duration of antiplatelet therapy, and the absence of residual foreign material in the vessel.
Drug Eluting Bollon
Protégé is powered with technology offering patient benefits with maximum drug available at lesionsite.
Introducing our innovative drug-coated balloon (DCB), Protégé with technology that ensures minimal drug loss during transition with patented technology.
